Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib Meeting Abstract
| Authors: | Jackman, D. M.; Sequist, L. V.; Cioffredi, L.; Gallegos Ruiz, M.; Janne, P. A.; Giaccone, G.; Miller, V. A.; Johnson, B. E. |
| Abstract Title: | Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 432s |
| Language: | English |
| ACCESSION: | WOS:000208457402885 |
| DOI: | 10.1200/jco.2008.26.15_suppl.8035 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8035 -- Source: Wos |
